These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35703122)
1. Design, synthesis and Kuzu B; Hepokur C; Turkmenoglu B; Burmaoglu S; Algul O Future Med Chem; 2022 Jul; 14(14):1027-1048. PubMed ID: 35703122 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities. Osmaniye D; Korkut Çelikateş B; Sağlık BN; Levent S; Acar Çevik U; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA Eur J Med Chem; 2021 Jan; 210():112979. PubMed ID: 33183865 [TBL] [Abstract][Full Text] [Related]
3. Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer. AboulWafa OM; Daabees HMG; El-Said AH Bioorg Chem; 2023 May; 134():106437. PubMed ID: 36842320 [TBL] [Abstract][Full Text] [Related]
4. In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors. Desai S; Desai V; Shingade S Bioorg Chem; 2020 Jan; 94():103382. PubMed ID: 31662214 [TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells. Omar AME; AboulWafa OM; Amr ME; El-Shoukrofy MS Bioorg Chem; 2021 Apr; 109():104752. PubMed ID: 33657444 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer. El-Ghobashy NM; El-Sayed SM; Shehata IA; El-Ashmawy MB Sci Rep; 2022 Sep; 12(1):16246. PubMed ID: 36171229 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and apoptotic effects of novel benzoxazole compounds. Kaya B; Yurttaş L; Akalın-Çiftçi G; Aksoy MO Z Naturforsch C J Biosci; 2023 Nov; 78(11-12):433-440. PubMed ID: 37903727 [TBL] [Abstract][Full Text] [Related]
8. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
9. Benzoxazole derivatives as new generation of anti-breast cancer agents. Omar AME; AboulWafa OM; El-Shoukrofy MS; Amr ME Bioorg Chem; 2020 Mar; 96():103593. PubMed ID: 32004897 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Abdelgawad MA; Bakr RB; Omar HA Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160 [TBL] [Abstract][Full Text] [Related]
11. Medicinal-Chemistry-Driven Approach to 2-Substituted Benzoxazole-Estradiol Chimeras: Synthesis, Anticancer Activity, and Early ADME Profile. Kovács F; Huliák I; Árva H; Kiricsi M; Erdős D; Kocsis M; Takács G; Balogh GT; Frank É ChemMedChem; 2023 Nov; 18(22):e202300352. PubMed ID: 37727903 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro cytotoxicity of benzoxazole-based PPARα/γ antagonists in colorectal cancer cell lines. Moreno-Rodríguez N; Laghezza A; Cerchia C; Sokolova DV; Spirina TS; De Filippis B; Romanelli V; Recio R; Fernández I; Loiodice F; Pokrovsky VS; Ammazzalorso A; Lavecchia A Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400086. PubMed ID: 38807029 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of the anticancer activity of 2-amino-aryl-7-aryl-benzoxazole compounds. Khajondetchairit P; Phuangsawai O; Suphakun P; Rattanabunyong S; Choowongkomon K; Gleeson MP Chem Biol Drug Des; 2017 Nov; 90(5):987-994. PubMed ID: 28544428 [TBL] [Abstract][Full Text] [Related]
15. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers. Qin J; Qu S; Zhu K; Cheng Y; Pan G; Jing W; Liu X; Sun X; Liu L Bioorg Med Chem; 2021 Feb; 32():116003. PubMed ID: 33461148 [TBL] [Abstract][Full Text] [Related]